Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / GENOMICS IMMUN
-
Total 13F shares
-
1,886,708
-
Share change
-
+17,225
-
Total reported value
-
$103,362,867
-
Price per share
-
$52.03
-
Number of holders
-
82
-
Value change
-
+$1,108,604
-
Number of buys
-
42
-
Number of sells
-
22
Institutional Holders of ISHARES TR - GENOMICS IMMUN (IDNA) as of Q2 2021
As of 30 Jun 2021 ISHARES TR - GENOMICS IMMUN (IDNA) had 82 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 1,886,708 shares of stock of the company.
Largest 10 holders included UBS Group AG, RETIREMENT CAPITAL STRATEGIES, Thrivent Financial for Lutherans, Wharton Business Group, LLC, BANK OF AMERICA CORP /DE/, LPL Financial LLC, Wealthcare Advisory Partners LLC, ROYAL BANK OF CANADA, Sharkey, Howes & Javer, and FIRST REPUBLIC INVESTMENT MANAGEMENT, INC..
This table shows 83 institutional shareholders of the security as of 30 Jun 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.